ArticleFrontiers in nutrition2025
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in US adults: results from the NHANES 2011-2018.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Association Between NHHR and Future Cardiovascular Disease Among Patients With CKM Stages 0-3: A Nationwide Prospective Cohort Study.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Article
- BMI partially mediates the association between the non-HDL-C/HDL-C ratio and depression in obese adults.Diabetology & metabolic syndrome · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The NHHR, which is the ratio of non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol (HDL-C), has been suggested to have a link to several metabolic diseases and cardiovascular diseases (CVD). However, its association with CVD mortality and all-cause mortality remains uncertain. Methods and results: Analyzing HDL-C and non-HDL-C used to calculate NHHR were sourced from the National Health and Nutrition Examination Survey (2011-2018). In this experiment, we utilized subgroup analysis to examine the robustness of the results obtained. This study excluded participants under 20 years of age and those with missing NHHR or mortality data, resulting in a final sample of 20,294 participants. We employed logistic regression models to assess the association between NHHR and all-cause mortality and CVD mortality. The NHHR was categorized into four groups (Q1-Q4) according to their values from small to large. In model 3, considering all covariates, individuals in Q4 of NHHR exhibited a 41% higher CVD mortality compared to Q1 (HR = 1.41, 95% CI 1.14, 1.74). To explore the potential non-linear relationships between NHHR and mortality, restricted cubic spline (RCS) and threshold saturation techniques were used. About NHHR and all-cause mortality, the results indicated an L-shaped association, with a breakpoint (K) at 1.18. To the left of this threshold, a negative association was identified (OR = 0.30, 95% CI 0.13, 0.67). But when NHHR is greater than 1.18, the relationship was positive (HR = 1.12, 95% CI 1.06, 1.18). Conclusion: All in all, maintaining NHHR within an optimal range in adults may help reduce the association connected with both all-cause and CVD mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.